Products for Research Use Only
RegisterLogin

Sugemalimab

CAT: 0931-T76714-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T76714-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
2256084-03-2
Target
PD-1/PD-L1
Related Pathways
Apoptosis, Immunology/Inflammation, Cell Cycle/Checkpoint
Purity
0.95
Bioactivity
Sugemalimab (CS1001) is a fully humanized, full-length monoclonal antibody targeting PD-L1. It cross-links PD-L1-positive tumor cells with macrophages, inducing antibody-dependent cellular cytotoxicity. Sugemalimab is being studied for EGFR mutation-negative and ALK-negative metastatic non-small cell lung cancer (NSCLC), advanced solid tumors, and lymphoma.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Alternative Products

CatalogName
HY-P99114-01Sugemalimab
GTR18337564-01Sugemalimab Antibody
WA3577Research Grade Sugemalimab
E55B0445Sugemalimab (Reference antibody)
ICH5278-10mgSugemalimab Biosimilar - Research Grade
A138570Sugemalimab Biosimilar (Monoclonal, IgG4)
21-968Sugemalimab - Research Grade Biosimilar
GTR18780758-01(Sugemalimab) Biosimilar Reference Antibody
GTR18697758-01Sugemalimab Human Monoclonal Antibody
A135046Sugemalimab Biosimilar (Monoclonal, IgG4-lambda)

Popular Products